SCHEMBL6034799

SCHEMBL6034799

Cn1c(=O)n(C)c2cc(C(=O)CCCCNCCc3ccccc3)ccc21

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
GLA P06280 1/20 0.51
LMNA P02545 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
BRD4 O60885 1/20 0.45
BRPF1 P55201 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
HTT P42858 1/20 0.44
THRB P10828 1/20 0.44
SIGMAR1 Q99720 4/20 0.44
TAAR1 Q96RJ0 2/20 0.43
DPP4 P27487 1/20 0.43
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4860132 0.99 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2GLALMNATSHR
SCHEMBL13988052 0.86 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2GLALMNAKDM4E
SCHEMBL13988066 0.86 THRB (0.47) ALDH1A1SMN1; SMN2GLALMNATSHR
SCHEMBL4862455 0.85 POLB (0.51) ALDH1A1SMN1; SMN2GLALMNAKDM4E
Hydrochloric Acid SCHEMBL4860667 0.84 POLB (0.50) ALDH1A1SMN1; SMN2GLALMNAKDM4E
SCHEMBL6034764 0.83 MAPT (0.48) ALDH1A1SMN1; SMN2GLABRD4BRPF1
Hydrochloric Acid SCHEMBL4850422 0.82 MAPT (0.48) ALDH1A1SMN1; SMN2GLABRD4BRPF1
SCHEMBL6035084 0.82 THRA (0.49) ALDH1A1SMN1; SMN2GLALMNATSHR
Hydrochloric Acid SCHEMBL4861422 0.81 THRA (0.48) ALDH1A1SMN1; SMN2GLALMNATSHR
SCHEMBL4860764 0.81 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2GLALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7132547-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-07 US claimed
US-20060063769-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-03-23 US claimed
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063769-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 ALDH1A1 118/4885SMN1; SMN2 1472/4885GLA 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.